
News|Slideshows|October 6, 2022
4 New Drugs Approved for Primary Care: Q3 2022
Author(s)Sydney Jennings
Advertisement
The third quarter has come and gone, which means Patient Care Online has compiled another list of drugs approved by the US Food and Drug Administration for conditions that are often seen in primary care. In the slides below, find details on a novel rapid-acting treatment for major depressive disorder that was the first of its kind to receive approval from FDA, a novel treatment for plaque psoraisis, and more.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Garetosmab for Adults With Fibrodysplasia Ossificans Progressiva
2
Dementia Prevention Research Expands Beyond Traditional Vascular Risk Factors
3
Once-Weekly Insulin Icodec Offers a Major Shift in Type 2 Diabetes Care
4
FDA Grants Priority Review to First-in-Class Ecopipam for Pediatric Tourette Syndrome
5






































































































































